Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anixa Biosciences

3.23
+0.04001.25%
Post-market: 3.300.0700+2.17%15:57 EDT
Volume:38.26K
Turnover:123.37K
Market Cap:104.04M
PE:-8.56
High:3.39
Open:3.19
Low:3.19
Close:3.19
Loading ...
May 28, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 21, 2025

Major Issues Report

Form 8-K - Current report
Mar 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jan 10, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 10, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 08, 2024

Major Issues Report

Form 8-K - Current report
Sep 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 04, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2024

Major Issues Report

Form 8-K - Current report
May 03, 2024

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Mar 22, 2024

Major Issues Report

Form 8-K - Current report
Mar 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jan 17, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 16, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jan 16, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Dec 07, 2023

Major Issues Report

Form 8-K - Current report
Sep 07, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 17, 2023

Major Issues Report

8-K - Current report
Mar 17, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]